Driving the Improvement of Lung Cancer Prognosis

Wenhua Liang¹, Jun Liu¹, Jianxing He²

Affiliations

¹ Department of Thoracic Oncology and Surgery, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou, China.
² Department of Thoracic Oncology and Surgery, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou, China. Electronic address: drjianxing.he@gmail.com.

PMID: 33049207
DOI: 10.1016/j.ccell.2020.09.008

Free article

Comment

Driving the Improvement of Lung Cancer Prognosis

Wenhua Liang et al. Cancer Cell. 2020.

Free article

. 2020 Oct 12;38(4):449-451.

doi: 10.1016/j.ccell.2020.09.008.

Authors

Wenhua Liang¹, Jun Liu¹, Jianxing He²

Affiliations

¹ Department of Thoracic Oncology and Surgery, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou, China.
² Department of Thoracic Oncology and Surgery, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou, China. Electronic address: drjianxing.he@gmail.com.

PMID: 33049207
DOI: 10.1016/j.ccell.2020.09.008

Abstract

An article in the New England Journal of Medicine reveals a significant reduction of incidence-based mortality of non-small cell lung cancer in the U.S. and attributes this improvement to the approval of targeted therapies.

PubMed Disclaimer

Comment on

The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. Howlader N, et al. N Engl J Med. 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623. N Engl J Med. 2020. PMID: 32786189 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Driving the Improvement of Lung Cancer Prognosis

Affiliations

Driving the Improvement of Lung Cancer Prognosis

Authors

Affiliations

Abstract

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical